Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • AJNR Awards
    • Low-Field MRI
    • Alzheimer Disease
    • ASNR Foundation Special Collection
    • Photon-Counting CT
    • View All
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home

User menu

  • Alerts
  • Log in

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

ASHNR American Society of Functional Neuroradiology ASHNR American Society of Pediatric Neuroradiology ASSR
  • Alerts
  • Log in

Advanced Search

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • AJNR Awards
    • Low-Field MRI
    • Alzheimer Disease
    • ASNR Foundation Special Collection
    • Photon-Counting CT
    • View All
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds

AJNR Awards, New Junior Editors, and more. Read the latest AJNR updates

Case of the Month

Section Editor: Nicholas Stence, MD
Children's Hospital Colorado, Aurora, CO

Submit a Case Previous Cases

December 2013
  • Description
  • Week 1
  • Week 2
  • Week 3
  • Week 4
  • Discussion
Loading

Next Case of the Month coming January 7 . . .

Vigabatrin-Associated Transient MRI Changes

  • Background and Clinical Features
    • Bilateral and symmetric signal abnormalities involving the basal ganglia, thalami, and dorsal brainstem in an infant necessitate a long list of differential considerations, including ischemic, toxic/metabolic, and infectious/inflammatory causes. Correlation with ancillary imaging, clinical history, and metabolic profile is key for limiting the differential list.
    • Vigabratrin-induced transient MRI signal changes represent a rare, yet important, radiological entity within the toxic subcategory. If recognized correctly, more extensive clinical work-up and/or treatment may be avoided.
    • Vigabatrin is an antiepileptic drug used for treating infantile spasms. Animal studies have described vigabatrin-associated intramyelin edema after prolonged administration. Such histological changes are less well-established in humans.
    • Studies in humans have documented reversible and marked MRI T2-hyperintensity and diffusion restriction in the globi pallidi, thalami, dorsal pons, and midbrain in up to 30% of infants undergoing treatment.
    • In a retrospective series by Milh et al, signal changes were transient, occurring between 1 to 12 months after initiating therapy. Maximal signal intensity occurred at 3 to 6 months with normalization after 12 months.
    • Affected children are less than two years old, and risk is related to younger age and higher dose, implying susceptibility of the developing brain; similar signal changes have not been described in adults treated with vigabatrin.
  • Key Diagnostic Features: Bilateral, symmetric, and marked T2 hyperintensity and diffusion restriction in the globi pallidi, thalami, dorsal pons, and midbrain in an infant on vigabatrin therapy. No associated enhancement, T1 signal changes, hemorrhage, or venous/arterial thrombosis. MR spectroscopy has a normal profile with absence of lactate or lipid peak.
  • DDx: Venous sinus thrombosis, postictal ischemia, hypoxic-ischemic injury, Leigh disease, mitochondrial disorder (MELAS)
  • Rx: Vigabatrin-associated MRI signal changes appear to be transient and unrelated to the epileptic syndrome, EEG patterns, or seizing activity. It is unclear whether MRI signal changes represent true toxicity warranting discontinuation of treatment. Clinical signs of vigabatrin toxicity may be more appropriate for guiding therapy.

Suggested Reading

Ropele S, Enzinger C, Söllinger M, et al. The impact of sex and vascular risk factors on brain tissue changes with aging: magnetization transfer imaging results of the Austrian Stroke Prevention Study. AJNR Am J Neuroradiol 2010;31:1297–1301. doi: 10.3174/ajnr.A2042

Milh M, Villeneuve N, Chapon F, et al. Transient brain magnetic resonance imaging hyperintensity in basal ganglia and brain stem of epileptic infants treated with vigabatrin. J Child Neurol 2009;24:305–15. doi: 10.1177/0883073808324219

Current Issue

American Journal of Neuroradiology: 46 (5)
American Journal of Neuroradiology
Vol. 46, Issue 5
1 May 2025
  • Table of Contents
  • Index by author
  • Complete Issue (PDF)
Sign up for alerts
Advertisement

Case Collections

Clasic Case Archive
Case of the Week Archive
Case of the Month Archive
Advertisement

Indexed Content

  • Current Issue
  • Accepted Manuscripts
  • Article Preview
  • Past Issues
  • Editorials
  • Editor's Choice
  • Fellows' Journal Club
  • Letters to the Editor
  • Video Articles

Cases

  • Case Collection
  • Archive - Case of the Week
  • Archive - Case of the Month
  • Archive - Classic Case

More from AJNR

  • Trainee Corner
  • Imaging Protocols
  • MRI Safety Corner

Multimedia

  • AJNR Podcasts
  • AJNR Scantastics

Resources

  • Turnaround Time
  • Submit a Manuscript
  • Submit a Video Article
  • Submit an eLetter to the Editor/Response
  • Manuscript Submission Guidelines
  • Statistical Tips
  • Fast Publishing of Accepted Manuscripts
  • Graphical Abstract Preparation
  • Imaging Protocol Submission
  • Evidence-Based Medicine Level Guide
  • Publishing Checklists
  • Author Policies
  • Become a Reviewer/Academy of Reviewers
  • News and Updates

About Us

  • About AJNR
  • Editorial Board
  • Editorial Board Alumni
  • Alerts
  • Permissions
  • Not an AJNR Subscriber? Join Now
  • Advertise with Us
  • Librarian Resources
  • Feedback
  • Terms and Conditions
  • AJNR Editorial Board Alumni

American Society of Neuroradiology

  • Not an ASNR Member? Join Now

© 2025 by the American Society of Neuroradiology All rights, including for text and data mining, AI training, and similar technologies, are reserved.
Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire